ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,555.74
      -0.16%
      US Tech 100
      19,008.00
      -1.13%
      Dow Jones
      40,358.09
      -0.14%
      Brent Oil
      81.095
      0.40%
      Bitcoin
      66,442.17
      0.79%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Brooklyn ImmunoTherapeutics Inc (BTX)

      7. Brooklyn ImmunoTherapeutics Inc (BTX) Financials

      Brooklyn ImmunoTherapeutics Inc

      Brooklyn ImmunoTherapeutics Inc (BTX)

      NASDAQ
      0.2051
      0.00
      (0.00%)
      Closed July 23 4:00PM
      Delayed by 15 minutes
      0.2051
      0.00
      ( 0.00% )
      Pre Market: 8:00PM
      Delayed by 15 minutes

      Brooklyn ImmunoTherapeutics Inc Financial Summary

      The current BTX market cap is 1.11M. The company's latest EPS is USD -4.0081 and P/E is -0.50.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 0051k17k47k
      Operating Income -5.32M-4.6M-5.51M-5.77M-5.79M
      Net Income -5.42M-4.52M-5.59M-6.16M-6.65M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 19.81M5.8M0068k
      Operating Income -1.76M-6.31M-113.73M-27.23M-21.14M
      Net Income -2.06M-4.43M-122.32M-24.6M-21.68M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 15.11M46.95M52.25M49.13M49.66M
      Total Liabilities 7.73M43.09M48.69M46.9M53.07M
      Total Equity 7.38M3.87M3.56M2.23M-3.41M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 14.13M3.75M32.43M22.28M49.13M
      Total Liabilities 9.03M2.89M25.93M10.17M46.9M
      Total Equity 5.09M851k6.5M12.11M2.23M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -6.05M-9.92M-15.75M-20.41M-3.75M
      Investing N/A N/A N/A -19k-97k
      Financing N/A 312k8.85M16.56M1.39M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 2.74M-3.89M-23.49M-20.98M-20.41M
      Investing -1.07M960k-22.74M-47k-19k
      Financing -1.1M291k61.59M19.58M16.56M

      Stats and Ratios

      Market Cap 1.11M
      Price to Earnings Ratio -0.50
      Price to Sales Ratio 158.73
      Price to Cash Ratio 1.43
      Price to Book Ratio 4.85
      Dividend Yield -

      Share Statistics

      Shares Outstanding 5.41M
      Average Volume (1 week) 0
      Average Volume (1 Month) 0
      52 Week Change -
      52 Week High -
      52 Week Low -
      Spread (Intraday) 0 (0.07%)

      Company Info

      Company Name Brooklyn ImmunoTherapeutics Inc
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://eternatx.com
      Industry television broadcast station (4833)